ABSTRACT
Background: Peru has been one of the countries with the highest burden of disease due to COVID-19. The Government of Peru has established basic guidelines for the preparation and registration of plans for the surveillance, prevention, and control of COVID-19 at work (PVPC) of Peruvian institutions. Objective:To characterize the PVPC of health sector institutions in Peru. Materials and Methods: retrospective descriptive secondary database study. The PVPCs of the health sector registered in the SISCOVID-Empresas platform of the Ministry of Health of Peru, mandatory registration for the reactivation of activities during the COVID-19 pandemic, were evaluated. Results: 1263 PVPC records from the health sector registered on the SISCOVID-Empresas platform were analyzed. Of the registered PVPCs, 5.8% of companies do not have a supervisor or committee for occupational safety and health, and 38.6% of companies with more than 20 workers do not have a health professional. Conclusions: A high non-compliance with what is required in the PVPCs in institutions of the Peruvian health sector was identified. It is necessary to reinforce and supervise the adequate fulfillment of the PVPC in these institutions.
ABSTRACT
The main objective was to estimate the prevalence of diabetes mellitus (DM) among patients with COVID-19, to explore associ-ated factors;and to describe clinical evolution of hospitalized patients. A cross-sectional study was conducted, which included adults confirmed with COVID-19 between 03/12/2020 and 10/15/2020, at Hospital Italiano de Buenos Aires. From 6009 people with COVID-19, 408 had previous diagnosis of DM, yielding a prevalence of 6% (95%CI 6-7), higher prevalence was associated with age (12% in ≥ 60 years and 3% in < 60 years;p = 0.01). In-hospital mortality was 6% (95%CI 6-7), being 15% in DM and 6% compared in non-diabetics (p < 0.01). Associated factors with DM were cardiovascular variables such as male sex, hypertension, smoking, chronic renal failure, heart failure, previous coronary disease;and clinical variables proxy of frailty such as: age, dementia and previous institutionalization (all with p < 0.01). Only 23% (96/408) of DM had an HbA1c measurement in the last 3 months and 76% in the last year, with an average 8.6%, and 25% in goal (HbA1c ≤ 7%). Management was mostly in-hospital (59%), with an average hospital stay of 12 days, with the following complications during hospitalization: 6% presented a hypoglycemic value (< 70 mg/dl), 42% required oxygen therapy, 19 % went to intensive care unit, 15% required invasive mechanical ventilation (mean 11 days), and 25% (95%CI 20-31) of in-hospital mortality (mean 82 years).